热门资讯> 正文
Trinity Capital承诺向Neuros Medical提供3500万美元的增长资本
2026-03-10 21:24
- Trinity Capital (TRIN) on Tuesday said it has committed $35 million in growth capital to Neuros Medical.
- The financing will support the expansion and commercialization of Neuros Medical’s Altius Direct Electrical Nerve Stimulation System, which is designed to treat chronic post-amputation pain.
- Neuros Medical said the funding will also help scale adoption of the therapy and support expansion into new markets.
- TRIN +1.41% premarket to $15.07.
- Source: Press Release
More on Trinity Capital
- Trinity Capital: Strong Investment Setup (Rating Upgrade)
- Trinity Capital: Not Your Typical 13%+ Yielding BDC
- Trinity Capital: NAV Growth Continues In Q4
- Trinity Capital outlines $1.2B in unfunded commitments and monthly dividend transition amid robust portfolio growth
- Trinity Capital posts preliminary Q4, full-year 2025 results
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。